(Reuters) - Pfizer Inc on Monday said it plans to internally separate its commercial operations into three business segments, including two units that sell patent-protected branded drugs and one that sells generic medicines.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
No comments:
Post a Comment